Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA).
2021
Figure 2A only (OS KM curve) if possible. However, Figure 2 is a two part figure (Figure 2A and 2B), and therefore if both 2A and 2B need to be included that is fine.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
32
References
2
Citations
NaN
KQI